Theralase Technologies Inc.
TLTFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,256 | -$4,571 | -$5,235 | -$4,411 |
| Dep. & Amort. | $272 | $286 | $313 | $276 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $521 | $621 | $192 | $318 |
| Change in WC | $103 | -$436 | -$422 | -$238 |
| Other Non-Cash | $34 | $26 | $49 | $24 |
| Operating Cash Flow | -$3,326 | -$4,073 | -$5,103 | -$4,030 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$20 | -$37 | -$70 | -$101 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$20 | -$37 | -$70 | -$101 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$117 | -$117 | -$76 | -$57 |
| Stock Issued | $3,690 | $2,763 | $2,722 | -$1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$1 | $344 | -$1 |
| Financing Cash Flow | $3,571 | $2,645 | $2,990 | -$57 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $225 | -$1,465 | -$2,183 | -$4,189 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $1,509 | $3,692 | $7,880 |
| End Cash | $269 | $44 | $1,509 | $3,692 |
| Free Cash Flow | -$3,346 | -$4,110 | -$5,173 | -$4,131 |